Back to Search
Start Over
Asher Bio Announced Publications in Cancer Discovery Highlighting the Differentiated Profile of AB248, its CD8+ T Cell Selective IL-2 Product Candidate
- Source :
- Plus Company Updates. April 4, 2024
- Publication Year :
- 2024
-
Abstract
- SOUTH SAN FRANCISCO: Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, today announced the publication of two manuscripts in Cancer Discovery, a journal of [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.792525170